BP and DuPont joint venture (JV), Butamax Advanced Biofuels, has announced that it has acquired Nesika Energy, LLC and its state-of-the-art ethanol facility in Scandia, Kansas. Butamax will now start the detailed engineering work to add bio-isobutanol capacity to the facility while continuing to produce ethanol before and after adding this capacity.
Butamax Advanced Biofuels LLC, a 50/50 joint venture (JV) between global oil and gas major BP PLC and DuPont, a global chemical and life-science corporation has revealed the next step in commercialisation of bio-isobutanol with the acquisition of Nesika Energy, LLC and its state-of-the-art ethanol facility in Scandia, Kansas.
Originally commissioned in 2008, Butamax will now start the detailed engineering work to add bio-isobutanol capacity to the 10 million US gallon per annum (≈ 37.85 million litre) facility while continuing to produce ethanol before and after adding this capacity.
– With the largest operated renewables business among the major oil companies, BP is committed to being a part of the global transition to a lower-carbon future. We invest in renewables where we believe we can build commercially viable businesses at scale, and this project, which brings together BP’s and DuPont’s complementary expertise, is another important step in that direction, said Dev Sanyal, BP’s chief executive of alternative energy in a statement.
Key platform chemical
Bio-isobutanol is a cost-effective alternative to isobutanol derived from fossil feedstock. Produced from renewable feedstocks, it offers both a valuable option for growing the renewable content of gasoline and a lower carbon alternative to fossil-derived isobutanol in existing chemical applications.
As a fuel, it can be blended with gasoline in higher concentrations than ethanol without compromising compatibility or performance. Bio-isobutanol blends do not suffer from the water solubility issues of ethanol, which means they can be transported via existing fuel pipelines. In the chemicals industry, it is used both directly and as an important platform chemical block for a wider range of products.
– To drive growth in US manufacturing, we must employ disruptive thinking and innovation to unlock the power of renewable raw materials. With the purchase and planned build-out of the Nesika facility to include bio-isobutanol production, Butamax is taking the next step forward in advancing the bioeconomy, which supports economic growth and opportunity in rural communities, said William F. Feehery, President, DuPont Industrial Biosciences.
DuPont, BP and Butamax have worked collaboratively with the State of Kansas on this exceptional opportunity. Partnering with the state on economic incentives and job creation is key to the joint venture’s success.
– We are pleased that Butamax has selected Kansas as the home of its first production facility. Kansas is a great state to locate for innovative, bio-based businesses looking for a skilled workforce, locally grown feedstocks and bioeconomy expertise, said Kansas Secretary of Commerce Antonio Soave.
Technology rollout planned
Butamax plans to license its proprietary bio-isobutanol technology beyond this first facility on a global scale. When the newly acquired facility in Kansas has bio-isobutanol production capability, it will be used as a demonstration facility for potential licensees to see the technology in operation and serve as a proving ground for future developments.
– We are pleased to announce the acquisition of the Nesika site and would like to welcome Nesika and its employees to Butamax. The Nesika facility will serve to demonstrate our technology at scale as well as validate the process and biocatalyst improvements. Our plan is to broadly license our technology, and Nesika and the technology deployed at the site will play a key role in that activity, said Stuart Thomas, CEO of Butamax.
An outcome of the 2003 Advanced Biofuel Program, Butamax Advanced Biofuels LLC was formed in 2006 to develop and commercialise bio-isobutanol as a next generation renewable biofuel and chemical. The company benefits from the combination of DuPont’s proven industrial biotechnology experience and BP’s global fuels market knowledge. Butamax’s proprietary technology offers a cost-advantaged manufacturing process for isobutanol with value from field to end use.
– We see Nesika Energy’s future to be full of growth and opportunity as a result of this sale to Butamax. The board and all the investor-owners are proud of Nesika’s past success and are excited that now, as a part of Butamax, Nesika will play an important role in the development of this new bio-isobutanol product while continuing to be an important member of this community, said Jerry Stowell, president of the board of directors of Nesika Energy.
